Member Info for MrJinx

Newbee, I think you’re forgetting that ‘no’ news this week is still effing amazing. No adverse reactions, no deteriorating patient symptoms, nothing that the market needs alerting to. As I said, amazing!!!

Read up on why, with just a three person cohort, it’s groundbreaking. To quote Haywain, “one or two out of the three is anecdotal. All three, is data”.

…and it’s the footy transfer deadline day. Could today be any more exciting?

…but then again, the speed of this re-rate, Vlad won’t have a chance to catch it at £10.. :0D

Warrants will raise what, a million? I’m talking about ridding Hemo of the scourge of fund raising altogether. Not for three or four months like now, or when the warrants are exercised.

I think at around £10, Vlad will fund raise. 200k shares for around £2m would be absolutely nothing on the total share count, yet secure Hemo financially for at least a year. It would make sense.

@ Kozz. I can almost guarantee that if this was still at old money, prior to consolidation, you wouldn’t have sold at 1.8p. I think people are getting confused by the £ sign.

This is still ridiculously cheap as chips!

@robsaunders99; what the **** are you blabbing about, yer fool? the latest fund raise didn’t catch anyone out. effing ******!

At least some sanity has returned to the market. This morning was nuts!

…and back up we go

MMs taking out stop losses and nervy punters at 540s, and then selling them at 615-630. Naughty.

Looks to have support at 525.

Halifax £5.40. Hell of a tree shake!!!

Halifax £6.40…

Did I just fleetingly see a sell at 438p? They must be effing nuts!!! :0D

Subush - forget CBR and CDX, for now. The market value of HG-CT1 hasn’t even been factored in. We’re not even at my original buy in price, which was two years before Hemo went clinical.

@MattP. If/when this gets to £28, you’d have to assume things are going very well indeed, so that would probably mean a deal has been signed or paediatric trials have gone really well. With that being the case, it won’t be just amateur punters jumping on to the Hemo train, it’ll be professional investors, fund managers and institutions. Maybe even the entity Hemo have hypothetically done a deal with.

Needless to say, there’ll be no concerns about buyers. 10% profit on a £1000 is still 10%, whether it’s 30 shares or 3000.

Spread is ridiculous

What’s the lower mCap trigger limit before most institutions will buy a stock? Is it £50m or £100m. Whichever it is, once they get involved, it’s to the stars and beyond. Think Dec onwards is going to be very exciting.

Sp - 353p